Skip to content
10-Q

Quarterly Report

KIORA PHARMACEUTICALS INC KPHMW KPRX

0001372514-26-000047

← back to feed
Filed
May 8, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 6, 2026 4.43M sh
Shares Diluted Q1 2026 · Mar 31, 2026 4.17M sh
Shares Diluted Q1 2026 · Mar 31, 2025 4.22M sh
Capex Q1 2026 · Mar 31, 2026 $5.02K
Capex Q1 2026 · Mar 31, 2025 $0
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$3.16M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$2.7M
Short Term Investments Q1 2026 · Mar 31, 2026 $2.92M
Short Term Investments Q1 2026 · Dec 31, 2025 $8.39M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $10.96M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $8.7M
Stockholders Equity Q1 2026 · Mar 31, 2026 $13.93M
Stockholders Equity Q1 2026 · Dec 31, 2025 $16.13M
Stockholders Equity restated Q1 2026 · Mar 31, 2025 $23.7M
Stockholders Equity Q1 2026 · Dec 31, 2024 $25.76M
Current Liabilities Q1 2026 · Mar 31, 2026 $2.8M
Current Liabilities Q1 2026 · Dec 31, 2025 $3.63M
Total Liabilities Q1 2026 · Mar 31, 2026 $7.29M
Total Liabilities Q1 2026 · Dec 31, 2025 $8.13M
Current Assets Q1 2026 · Mar 31, 2026 $18.68M
Current Assets Q1 2026 · Dec 31, 2025 $21.75M
Total Assets Q1 2026 · Mar 31, 2026 $21.23M
Total Assets Q1 2026 · Dec 31, 2025 $24.25M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.58
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.52
Eps Basic Q1 2026 · Mar 31, 2026 −$0.58
Eps Basic Q1 2026 · Mar 31, 2025 −$0.52
Sga Expense Q1 2026 · Mar 31, 2026 $1.61M
Sga Expense Q1 2026 · Mar 31, 2025 $1.49M
Rd Expense Q1 2026 · Mar 31, 2026 $2.12M
Rd Expense Q1 2026 · Mar 31, 2025 $2.53M
Net Income Q1 2026 · Mar 31, 2026 −$2.42M
Net Income Q1 2026 · Mar 31, 2025 −$2.19M
Operating Income Q1 2026 · Mar 31, 2026 −$2.51M
Operating Income Q1 2026 · Mar 31, 2025 −$2.33M